(Q37768590)

22 August 2017

1 reference

title

Management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategies (English)

1 reference

22 August 2017

main subject

arterial hypertension

0 references

1 reference

Brianne L Dunn

1

1 reference

22 August 2017

Ashley C Teusink

2

1 reference

22 August 2017

David J Taber

3

1 reference

22 August 2017

Brian A Hemstreet

4

1 reference

22 August 2017

Lynn A Uber

5

1 reference

22 August 2017

Nicole A Weimert

6

1 reference

22 August 2017

language of work or name

English

0 references

publication date

29 June 2010

1 reference

Annals of Pharmacotherapy

22 August 2017

published in

1 reference

22 August 2017

volume

44

1 reference

22 August 2017

issue

7-8

1 reference

22 August 2017

page(s)

1259-1270

1 reference

Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009.

22 August 2017

cites work

1 reference

Reducing the risks of cardiovascular disease in liver allograft recipients

21 January 2018

1 reference

A practical guide to the management of hypertension in renal transplant recipients

21 January 2018

1 reference

Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors

21 January 2018

1 reference

Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade

21 January 2018

1 reference

Management of cardiovascular disease in renal transplant recipients

21 January 2018

1 reference

Cardiovascular complications after renal transplantation and their prevention.

21 January 2018

1 reference

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials.

21 January 2018

1 reference

Hypertension after Kidney Transplantation: Impact, Pathogenesis and Therapy

21 January 2018

1 reference

Calcium channel blockers as the treatment of choice for hypertension in renal transplant recipients: fact or fiction.

21 January 2018

1 reference

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

21 January 2018

1 reference

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

21 January 2018

1 reference

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril

21 January 2018

1 reference

Pharmacokinetic interaction between tacrolimus and diltiazem: dose-response relationship in kidney and liver transplant recipients

21 January 2018

1 reference

Angiotensin-converting enzyme inhibitors after renal transplantation

21 January 2018

1 reference

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period

21 January 2018

1 reference

A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period

21 January 2018

1 reference

The effect of ACE inhibitor and angiotensin II blocker therapy on early posttransplant kidney graft function

21 January 2018

1 reference

The renin angiotensin system blockade in kidney transplantation: pros and cons

21 January 2018

1 reference

Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence

21 January 2018

1 reference

No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report

21 January 2018

1 reference

Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation

21 January 2018

1 reference

How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis

21 January 2018

1 reference

Withdrawal syndrome following cessation of antihypertensive drug therapy

21 January 2018

1 reference

Minoxidil attenuates ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes

21 January 2018

1 reference

Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients

21 January 2018

1 reference

Does the hyperfiltration of minoxidil result in increased proteinuria and loss of renoprotection conferred by angiotensin inhibition?

21 January 2018

1 reference

Drug therapy for hypertension in hemodialysis patients

21 January 2018

1 reference

Rebound hypertension following minoxidil withdrawal

21 January 2018

1 reference

Prevention of interstitial fibrosis of renal allograft by angiotensin II blockade

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1P004

1 reference

22 August 2017

1 reference